Skip to main content

Clovis Oncology, Inc.

CLVSDelisted Dec 29, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001466301

Clovis Oncology, Inc. was delisted on Dec 29, 2022; its insiders filed their last Form 4 on Nov 3, 2022; 103 institutions reported holding it in 13F filings for Q3 2022, worth $42.6M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Clovis Oncology, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of CLVS: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders01+1
Shares0229+229
Value$0$11.0K+$11.0K

New holders (1)

Institutions that held Clovis Oncology, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CLVS in Q3 2023
InstitutionSharesValue% of portfolio
Coppell Advisory Solutions LLC229$11.0K0.00%

Sold out (0)

Institutions that held Clovis Oncology, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

None.